Src homology domains in phospholipase C-gamma1 mediate its anti-apoptotic action through regulating the enzymatic
1Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Abstract:
Phospholipase-gamma1 (PLC-gamma1) prevents programmed cell death, for which the enzymatic activity has been implicated. However, the biological function of Src homology (SH) domains of PLC-gamma1 in promoting cell survival remains elusive. Here, we showed that deletion of the N-SH2 domain or both N-SH2 and C-SH2 domains, but not the SH3 domain, abolished the anti-apoptotic activity of PLC-gamma1. Surprisingly, removal of the whole SH domain inhibited apoptosis. The lipase-inactive PLC-gamma1 mutant (LIM) failed to suppress apoptosis. Moreover, the phospholipase activity in SH3- or whole SH domain-deleted cells was comparable to that of wild-type cells. By contrast, the enzymatic activity was substantially ablated in SH2 domain-deleted or LIM cells. A pharmacological inhibitor of PLC-gamma1 robustly diminished the anti-apoptotic action in wild-type, SH3- or whole SH domain-deleted cells, whereas pretreatment of SH2 domain-deleted or LIM cells with agents activating PKC and calcium mobilization markedly promoted cell survival. These results indicate that SH domains in PLC-gamma1 might mediate its anti-apoptotic action by regulating the enzymatic activity.
Insights
Phospholipase-gamma1 (PLC-gamma1) protects cells from programmed cell death. Its Src homology (SH) domains are crucial for this anti-apoptotic function, likely by regulating enzymatic activity.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Phospholipase-gamma1 (PLC-gamma1) is known to prevent programmed cell death.
- The specific role of its Src homology (SH) domains in cell survival is not well understood.
Purpose of the Study:
- To investigate the function of PLC-gamma1's SH domains in promoting cell survival.
- To elucidate the mechanism by which PLC-gamma1 exerts its anti-apoptotic effects.
Main Methods:
- Genetic manipulation of PLC-gamma1, including deletion of specific SH domains (N-SH2, C-SH2, SH3) and creation of a lipase-inactive mutant (LIM).
- Assessment of anti-apoptotic activity and phospholipase activity in modified PLC-gamma1 cells.
- Pharmacological inhibition and activation of signaling pathways (PKC, calcium mobilization).
Main Results:
- Deletion of N-SH2 or both N-SH2 and C-SH2 domains abolished PLC-gamma1's anti-apoptotic activity.
- Removal of the entire SH domain also inhibited apoptosis, while SH3 domain deletion did not affect this function.
- Lipase-inactive PLC-gamma1 (LIM) failed to suppress apoptosis, and its enzymatic activity was ablated.
- Enzymatic activity was comparable in SH3 or whole SH domain-deleted cells but reduced in SH2 domain-deleted or LIM cells.
- Pharmacological inhibition of PLC-gamma1 reduced anti-apoptotic effects in wild-type and SH3/whole SH domain-deleted cells.
- Activation of PKC and calcium mobilization promoted survival in SH2 domain-deleted or LIM cells.
Conclusions:
- PLC-gamma1's SH domains are critical for its anti-apoptotic function.
- The anti-apoptotic role of PLC-gamma1 appears to be mediated by its enzymatic activity, which is regulated by the SH domains.
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
IP3/DAG Signaling Pathway
Caspases
Membrane Asymmetry Regulating Transporters
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...


